Loading clinical trials...
Loading clinical trials...
INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes
Conditions
Interventions
Technosphere Insulin
Technosphere Insulin
+1 more
Locations
10
United States
Children's Hospital Los Angeles
Los Angeles, California, United States
University of California San Francisco
San Francisco, California, United States
Barbara Davis Center for Diabetes Young Adult Clinic
Aurora, Colorado, United States
Yale University
New Haven, Connecticut, United States
University of Florida
Gainsville, Florida, United States
Indiana University
Indianapolis, Indiana, United States
Start Date
February 4, 2026
Primary Completion Date
March 1, 2027
Completion Date
September 1, 2027
Last Updated
April 21, 2026
NCT07051005
NCT06575426
NCT06390371
NCT06786130
NCT03228732
NCT07179471
Lead Sponsor
Mannkind Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions